Single intravitreal ranibizumab for myopic choroidal neovascularization
Saidin Nor-Masniwati, Ismail Shatriah, Embong ZunainaDepartment of Ophthalmology, Universiti Sains Malaysia, Kelantan, MalaysiaAbstract: We report a case of myopic choroidal neovascularization that showed improvement after a single injection of ranibizumab. A 45-year-old Chinese man with high myopia...
Guardado en:
Autores principales: | Shatriah I, Nor-Masniwati S, Zunaina E |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8dfcc821f4b54f369c1fd6f45903fa64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis D, et al.
Publicado: (2017) -
Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban AA, et al.
Publicado: (2012) -
Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
por: Bhurayanontachai P, et al.
Publicado: (2011) -
Current and emerging treatment options for myopic choroidal neovascularization
por: El Matri L, et al.
Publicado: (2015) -
Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
por: Roberto Gallego-Pinazo, et al.
Publicado: (2011)